key: cord-0834560-zjquwfva
authors: Wainstein, M.; Macdonald, S.; Fryer, D.; Young, K.; Webb, S. A.; Begum, H.; Nichol, A.; Lee, J.; Balan, V.; Cobb, J. P.; Burrell, A.; Kennon, K.; Strudwick, S.; Kelly, S.; Semple, M. G.; Merson, L.; Citarella, B.; Murthy, S.; Rossignol, P.; Claure-Del Granado, R.; Shrapnel, S.
title: Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study of the ISARIC cohort
date: 2022-03-21
journal: nan
DOI: 10.1101/2022.03.18.22272601
sha: 49daf75fb0c09a9c0b49f7625a3789cde4c7791f
doc_id: 834560
cord_uid: zjquwfva

Background: Acute kidney injury (AKI) is one of the most common and significant problems in patients with COVID-19. However, little is known about the incidence and impact of AKI occurring in the community or early in the hospital admission. The traditional KDIGO definition can fail to identify patients for whom hospitalization coincides with recovery of AKI as manifested by a decrease in serum creatinine (sCr). We hypothesized that an extended KDIGO definition, adapted from the International Society of Nephrology 0by25 studies, would identify more cases of AKI in patients with COVID-19 and that these may correspond to community-acquired AKI with similarly poor outcomes as previously reported in this population. Methods and Findings: All individuals in the ISARIC cohort admitted to hospital with SARS-CoV-2 infection from February 15th, 2020, to February 1st, 2021, were included in the study. Data was collected and analysed for the duration of a patients admission. Incidence, staging and timing of AKI were evaluated using a traditional and extended KDIGO (eKDIGO) definition which incorporated a commensurate decrease in serum creatinine. Patients within eKDIGO diagnosed with AKI by a decrease in sCr were labelled as deKDIGO. Clinical characteristic and outcomes - intensive care unit (ICU) admission, invasive mechanical ventilation and in-hospital death - were compared for all three groups of patients. The relationship between eKDIGO AKI and in-hospital death was assessed using survival curves and logistic regression, adjusting for disease severity and AKI susceptibility. 75,670 patients from 54 countries were included in the final analysis cohort. Median length of admission was 12 days (IQR 7, 20). There were twice as many patients with AKI identified by eKDIGO than KDIGO (31.7 vs 16.8%). Those in the eKDIGO group had a greater proportion of stage 1 AKI (58% vs 36% in KDIGO patients). Peak AKI occurred early in the admission more frequently among eKDIGO than KDIGO patients. Compared to those without AKI, patients in the eKDIGO group had worse renal function on admission, more in-hospital complications, higher rates of ICU admission (54% vs 23%) invasive ventilation (45% vs 15%) and increased mortality (38% vs 19%). Patients in the eKDIGO group had a higher risk of in-hospital death than those without AKI (adjusted OR: 1.78, 95% confidence interval: 1.71-1.8, p-value < 0.001). Mortality and rate of ICU admission were lower among deKDIGO than KDIGO patients (25% vs 50% death and 35% vs 70% ICU admission) but significantly higher when compared to patients with no AKI (25% vs 19% death and 35% vs 23% ICU admission) (all p values < 5x10-5). Limitations include ad hoc sCr sampling, exclusion of patients with less than two sCr measurements, and limited availability of sCr measurements prior to initiation of acute dialysis. Conclusions: The use of an extended KDIGO definition to diagnose AKI in this population resulted in a significantly higher incidence rate compared to traditional KDIGO criteria. These additional cases of AKI appear to be occurring in the community or early in the hospital admission and are associated with worse outcomes than those without AKI.

5 24 by eKDIGO than KDIGO (31.7 vs 16.8%). Those in the eKDIGO group had a greater 25 proportion of stage 1 AKI (58% vs 36% in KDIGO patients). Peak AKI occurred early in the 26 admission more frequently among eKDIGO than KDIGO patients. Compared to those 27 without AKI, patients in the eKDIGO group had worse renal function on admission, more in-28 hospital complications, higher rates of ICU admission (54% vs 23%) invasive ventilation 29 (45% vs 15%) and increased mortality (38% vs 19%). Patients in the eKDIGO group had a 30 higher risk of in-hospital death than those without AKI (adjusted OR: 1.78, 95% confidence 31 interval: 1.71-1.8, p-value < 0.001). Mortality and rate of ICU admission were lower among 32 deKDIGO than KDIGO patients (25% vs 50% death and 35% vs 70% ICU admission) but 33 significantly higher when compared to patients with no AKI (25% vs 19% death and 35% vs 34 23% ICU admission) (all p values < 5x10 -5 ). Limitations include ad hoc sCr sampling, 35 exclusion of patients with less than two sCr measurements, and limited availability of sCr 36 measurements prior to initiation of acute dialysis. 37 38 Conclusions: The use of an extended KDIGO definition to diagnose AKI in this 39 population resulted in a significantly higher incidence rate compared to traditional KDIGO 40 criteria. These additional cases of AKI appear to be occurring in the community or early in 41 the hospital admission and are associated with worse outcomes than those without AKI. 

The integration of this additional criteria to identify kidney injury has also been 99 highlighted as one of the research priorities in the recent KDIGO report on controversies in 100 AKI [8] . While other papers have indicated the need to revise various aspects of the KDIGO 101 criteria, aside from the 0by25 studies, a decrease in serum creatinine as a marker of AKI has . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 21, 2022. ; https://doi.org/10.1101/2022.03.18.22272601 doi: medRxiv preprint 147 measurements during the admission and those with incomplete or unreliable laboratory data 148 were also excluded (Fig 1) . AKI was identified biochemically using sCr and incidence rates calculated accordingly. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Table 2 , 3 and 4 and further information on its distribution is presented in S3 Table. 222 A logistic regression was fitted to assess the association between eKDIGO AKI with 223 in-hospital mortality. A t-test with a significance threshold of 0.001 was used to assess the 224 significance of predictors. MICE imputation was used to address variable missingness and a 225 sensitivity analysis showing the results without imputation can be found in S4 Table. 226 Adjustments were made for factors indicating disease severity such as: admission to ICU; need for 227 mechanical ventilation; corticosteroid and antifungal treatment; complicating factors such as . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint (Fig. 1) . The median length of admission was 12 days (IQR 7, 20 days). Missing data was less 247 than 10% for most variables-although averaging 20% for symptoms on admission-and 248 distributed evenly between groups for those with higher missingness levels (S3 Table) .

. CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 260 (64% of all AKI on that day) (Fig 4) . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 21, 2022. ; https://doi.org/10.1101/2022.03.18.22272601 doi: medRxiv preprint 318 (38%) compared to patients without AKI. After adjusting for disease severity, this group of 319 patients had a higher risk of in-hospital death (OR: 1.77, 95% CI: 1.7-1.85, p-value < 0.001) 320 (Table 5) which is further illustrated in the survival curves shown in Fig 5. Patients in the 321 deKDIGO group appeared to have better outcomes and less mortality than those diagnosed 322 by KDIGO criteria, but still had significantly worse outcomes and mortality than patients 323 with no AKI (Tables 3 and 4) . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

This study has some key limitations. The exclusion of patients without two sCr 393 measurements may have introduced a degree of selection bias. This could be responsible for 394 the absence of expected geographical differences found between the eKDIGO and no AKI 395 groups and may also have resulted in an underestimation of AKI cases by both definitions [6].

396 The lack of a time-standardized collection of sCr across all sites also represents a limitation of 397 the study. Patients having more frequent sCr collections may represent a population with more 398 severe illness in whom AKI would be more readily detected, therefore affecting the overall 399 AKI incidence rates and potentially generating a negative survival bias. Nevertheless, it is 400 reassuring that the number of AKI cases are a small proportion of the total sCr collected on any 401 given day (<18%) (S2 Fig), suggesting that the bias introduced by ad hoc sampling was low.

402 The lack of standardization in sCr collection may have also affected the reporting of time to 403 peak AKI, the magnitude of peak AKI reached in each individual patient and, in those . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 21, 2022. ; https://doi.org/10.1101/2022.03.18.22272601 doi: medRxiv preprint

sCr during their admission, whether AKI was captured 405 during the former phase (KDIGO) or the latter (eKDIGO)

Such a definition would preclude many 408 patients in this study who were identified as having AKI on day 3 of admission. It is worth 409 noting that these patients would be identified as CA-AKI (or transient hospital-associated AKI) 410 by the definition proposed by Warnock et al which integrates serum creatinine trajectories and 411 doesn

To our knowledge, this is the first study to systematically examine an extended KDIGO 415 definition for the identification of AKI against the traditional KDIGO criteria in hospitalized

Our population is, as far as we know, the largest and only multinational 417 cohort of patients with COVID-19 from all income country levels. The use of an extended 418 KDIGO definition to diagnose AKI in this population resulted in a significantly higher 419 incidence rate compared to traditional KDIGO criteria. These additional cases of AKI appear 420 to be occurring in the community or early in the hospital admission and are associated with 421 significantly worse outcomes

Outcomes 430 among patients hospitalized with COVID-19 and acute kidney injury

Kidney disease is 433 associated with in-hospital death of patients with COVID-19

COVID-19-associated acute kidney injury

Clinical practice guideline for acute kidney injury

Recognition and management of acute kidney injury in the International Society of Nephrology 442 0by25 Global Snapshot: a multinational cross-sectional study

Recognition and management of community-acquired acute kidney injury in low-446 resource settings in the ISN 0by25 trial: A multi-country feasibility study

Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global 450 Outcomes (KDIGO) Conference

Commonly used surrogates for baseline renal function affect the classification and prognosis 454 of acute kidney injury

International Criteria for Acute Kidney 456 Injury: Advantages and Remaining Challenges

Analysis Plan: Acute Kidney Injury in COVID-19 2020

All of statistics : a concise course in statistical inference

An empirical transition matrix for non-homogeneous Markov 467 chains based on censored observations

Welcome to the tidyverse

Outcomes for patients with COVID-19 and acute kidney injury: a systematic review and meta

Acute kidney injury 475 in patients hospitalized with COVID-19

Acute kidney injury in a 477 national cohort of hospitalized US veterans with COVID-19

Acute 480 kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: 481 a prospective, multicentre cohort study

Mild Stage 1 post-operative acute kidney injury: association with chronic kidney disease and 484 long-term survival

Three-year outcomes after 486 acute kidney injury: results of a prospective parallel group cohort study

Kidney Outcomes in Long COVID

World Incidence of AKI: A Meta-Analysis

Surveillance of influenza and other seasonal respiratory viruses 497 in the UK Winter

hospital-acquired acute kidney injury in hospitalised COVID-19 patients

Creatinine Trajectories for Community-versus Hospital-Acquired Acute Kidney Injury

S2 Table. Definition of comorbidities, complications and outcomes from the ISARIC case 513 report forms

Distribution of missingness information between eKDIGO and No AKI patients

Logistic regression fitted to assess the association between eKDIGO AKI with in-516 hospital mortality without MICE imputation for variable missingness

Breakdown of top contributing countries for patients diagnosed with AKI by KDIGO 518 definition (A) and from deKDIGO group (B)

Number of AKI cases by AKI definition (A = KDIGO and B = eKDIGO) as a

WBC (x10 9 /L) 8.1 (5.1, 11.1) 7 (4.5, 9.5) 15 p < 5x10 -5